6,149
Views
72
CrossRef citations to date
0
Altmetric
Reviews

n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review

, , , & ORCID Icon

References

  • Adachi, Y., L. E. Moore, B. U. Bradford, W. Gao, and R. G. Thurman. 1995. Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 108 (1):218–224.
  • Addolorato, G., E. Capristo, A. V. Greco, G. F. Stefanini, and G. Gasbarrini. 1997. Energy expenditure, substrate oxidation, and body composition in subjects with chronic alcoholism: New findings from metabolic assessment. Alcohol. Alcoholism: Clinical and Experimental Research 21:962–967.
  • Addolorato, G., E. Capristo, A. V. Greco, G. F. Stefanini, and G. Gasbarrini. 1998. Influence of chronic alcohol abuse on body weight and energy metabolism: Is excess ethanol consumption a risk factor for obesity or malnutrition? Journal of Internal Medicine 244 (5):387–395.
  • Albano, E. 2008. Oxidative mechanisms in the pathogenesis of alcoholic liver disease. Molecular Aspects of Medicine 29 (1–2):9–16.
  • Aliche-Djoudi, F., N. Podechard, M. Chevanne, P. Nourissat, D. Catheline, P. Legrand, M. T. Dimanche-Boitrel, D. Lagadic-Gossmann, and O. Sergent. 2011. Physical and chemical modulation of lipid rafts by a dietary n-3 polyunsaturated fatty acid increases ethanol-induced oxidative stress. Free Radical Biology and Medicine 51 (11):2018–2030.
  • Aliche-Djoudi, F., N. Podechard, A. Collin, M. Chevanne, E. Provost, M. Poul, L. Le Hegarat, D. Catheline, P. Legrand, M. T. Dimanche-Boitrel, et al. 2013. A role for lipid rafts in the protection afforded by docosahexaenoic acid against ethanol toxicity in primary rat hepatocytes. Food and Chemical Toxicology 60:286–296.
  • Altamirano, J., and R. Bataller. 2011. Alcoholic liver disease: Pathogenesis and new targets for therapy. Nature Reviews. Gastroenterology & Hepatology 8 (9):491–501.
  • Aroor, A. R., D. E. Jackson, and S. D. Shukla. 2011. Elevated activation of ERK1 and ERK2 accompany enhanced liver injury following alcohol binge in chronically ethanol-fed rats. Alcoholism: Clinical and Experimental Research 35:2128–2138.
  • Astarita, G., A. C. Kendall, E. A. Dennis, and A. Nicolaou. 2015. Targeted lipidomic strategies for oxygenated metabolites of polyunsaturated fatty acids. Biochimica et Biophysica Acta 1851 (4):456–468.
  • Awada, M., C. O. Soulage, A. Meynier, C. Debard, P. Plaisancie, B. Benoit, G. Picard, E. Loizon, M. A. Chauvin, M. Estienne, et al. 2012. Dietary oxidized n-3 PUFA induce oxidative stress and inflammation: Role of intestinal absorption of 4-HHE and reactivity in intestinal cells. Journal of Lipid Research 53 (10):2069–2080.
  • Barcelo-Coblijn, G., and E. J. Murphy. 2009. Alpha-linolenic acid and its conversion to longer chain n-3 fatty acids: Benefits for human health and a role in maintaining tissue n-3 fatty acid levels. Progress in Lipid Research 48:355–374.
  • Basuroy, S., P. Sheth, C. M. Mansbach, and R. K. Rao. 2005. Acetaldehyde disrupts tight junctions and adherens junctions in human colonic mucosa: Protection by EGF and L-glutamine. American Journal of Physiology: Gastrointestinal and Liver Physiology 289 (2):G367–G375.
  • Bataller, R., and D. A. Brenner. 2005. Liver fibrosis. The Journal of Clinical Investigation 115 (2):209–218.
  • Beckman, J. S., T. W. Beckman, J. Chen, P. A. Marshall, and B. A. Freeman. 1990. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proceedings of the National Academy of Sciences of the United States of America 87 (4):1620–1624.
  • Bellenger, J., S. Bellenger, A. Bataille, K. A. Massey, A. Nicolaou, M. Rialland, C. Tessier, J. X. Kang, and M. Narce. 2011. High pancreatic n-3 fatty acids prevent STZ-induced diabetes in fat-1 mice: Inflammatory pathway inhibition. Diabetes 60 (4):1090–1099.
  • Bertola, A., S. Mathews, S. H. Ki, H. Wang, and B. Gao. 2013. Mouse model of chronic and binge ethanol feeding (the NIAAA model). Nature Protocols 8 (3):627–637.
  • Brenna, J. T. 2002. Efficiency of conversion of alpha-linolenic acid to long chain n-3 fatty acids in man. Current Opinion in Clinical Nutrition and Metabolic Care 5 (2):127–132.
  • Brenna, J. T., N. Salem, Jr., A. J. Sinclair, S. C. Cunnane; International society for the study of Fatty acids and lipids. 2009. Alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukotrienes and Essential Fatty Acids 80 (2–3):85–91.
  • Calder, P. C. 2015. Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance. Biochimica et Biophysica Acta 1851 (4):469–484.
  • Chayanupatkul, M., and S. Liangpunsakul. 2014. Alcoholic hepatitis: A comprehensive review of pathogenesis and treatment. World Journal of Gastroenterology 20 (20):6279–6286.
  • Chen, J. R., Y. L. Chen, H. C. Peng, Y. A. Lu, H. L. Chuang, H. Y. Chang, H. Y. Wang, Y. J. Su, and S. C. Yang. 2016. Fish oil reduces hepatic injury by maintaining normal intestinal permeability and microbiota in chronic Ethanol-Fed rats. Gastroenterology Research and Practice 2016:1.
  • Day, C. P., and O. F. James. 1998. Hepatic steatosis: innocent bystander or guilty party? Hepatology (Baltimore, Md.) 27 (6):1463–1466.
  • de Castro, G. S., and P. C. Calder. 2018. Non-alcoholic fatty liver disease and its treatment with n-3 polyunsaturated fatty acids. Clinical Nutrition (Edinburgh, Scotland) 37 (1):37–55.
  • Ding, R. B., K. Tian, Y. W. Cao, J. L. Bao, M. Wang, C. He, Y. Hu, H. Su, and J. B. Wan. 2015. Protective effect of panax notoginseng saponins on acute ethanol-induced liver injury is associated with ameliorating hepatic lipid accumulation and reducing ethanol-mediated oxidative stress. Journal of Agricultural and Food Chemistry 63 (9):2413–2422.
  • Ding, R. B., K. Tian, L. L. Huang, C. W. He, Y. Jiang, Y. T. Wang, and J. B. Wan. 2012. Herbal medicines for the prevention of alcoholic liver disease: A review. Journal of Ethnopharmacology 144 (3):457–465.
  • Donohue, T. M., T. V. Curry-McCoy, A. A. Nanji, K. K. Kharbanda, N. A. Osna, S. J. Radio, S. L. Todero, R. L. White, and C. A. Casey. 2007. Lysosomal leakage and lack of adaptation of hepatoprotective enzyme contribute to enhanced susceptibility to ethanol-induced liver injury in female rats. Alcoholism: Clinical and Experimental Research 31 (11):1944–1952.
  • Donohue, T. M., Jr., K. K. Kharbanda, C. A. Casey, and A. A. Nanji. 2004. Decreased proteasome activity is associated with increased severity of liver pathology and oxidative stress in experimental alcoholic liver disease. Alcoholism: Clinical and Experimental Research 28 (8):1257–1263.
  • El-Assal, O., F. Hong, W. H. Kim, S. Radaeva, and B. Gao. 2004. IL-6-deficient mice are susceptible to ethanol-induced hepatic steatosis: IL-6 protects against ethanol-induced oxidative stress and mitochondrial permeability transition in the liver. Cellular and Molecular Immunology. 1:205–211.
  • Farhadi, A., A. Banan, J. Fields, and A. Keshavarzian. 2003. Intestinal barrier: An interface between health and disease. Journal of Gastroenterology and Hepatology 18(5):479–497.
  • Fischer, M., M. You, M. Matsumoto, and D. W. Crabb. 2003. Peroxisome proliferator-activated receptor alpha (PPARalpha) agonist treatment reverses PPARalpha dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice. Journal of Biological Chemistry 278(30):27997–28004.
  • Fu, Z., and A. J. Sinclair. 2000. Increased alpha-linolenic acid intake increases tissue alpha-linolenic acid content and apparent oxidation with little effect on tissue docosahexaenoic acid in the guinea pig. Lipids 35:395–400.
  • Fujimoto, M., M. Uemura, Y. Nakatani, S. Tsujita, K. Hoppo, T. Tamagawa, H. Kitano, M. Kikukawa, T. Ann, Y. Ishii., et al. 2000. Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance. Alcoholism: Clinical and Experimental Research 24:48S–54S.
  • Gao, B., and R. Bataller. 2011. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 141(5):1572–1585.
  • Ghosh Dastidar, S., J. B. Warner, D. R. Warner, C. J. McClain, and I. A. Kirpich. 2018. Rodent models of alcoholic liver disease: Role of binge ethanol administration. Biomolecules 8(1):3.
  • Han, H.,. F. Qiu, H. Zhao, H. Tang, X. Li, and D. Shi. 2017. Dietary flaxseed oil prevents western-type diet-induced nonalcoholic fatty liver disease in Apolipoprotein-E knockout mice. Oxidative Medicine and Cellular Longevity 2017:1.
  • Hanck, C., S. Rossol, U. Bocker, M. Tokus, and M. V. Singer. 1998. Presence of plasma endotoxin is correlated with tumour necrosis factor receptor levels and disease activity in alcoholic cirrhosis. Alcohol Alcohol 33(6):606–608.
  • Holman, R. T., and S. Johnson. 1981. Changes in essential fatty acid profile of serum phospholipids in human disease. Progress In Lipid Research 20:67–73.
  • Holmes, R. S., J. A. Duley, E. M. Algar, P. B. Mather, and U. K. Rout. 1986. Biochemical and genetic studies on enzymes of alcohol metabolism: the mouse as a model organism for human studies. Alcohol and Alcoholism 21:41–56.
  • Honchel, R., M. B. Ray, L. Marsano, D. Cohen, E. Lee, S. Shedlofsky, and C. J. McClain. 1992. Tumor necrosis factor in alcohol enhanced endotoxin liver injury. Alcoholism: Clinical and Experimental Research 16 (4):665–669.
  • Hong, F., W. H. Kim, Z. Tian, B. Jaruga, E. Ishac, X. Shen, and B. Gao. 2002. Elevated interleukin-6 during ethanol consumption acts as a potential endogenous protective cytokine against ethanol-induced apoptosis in the liver: Involvement of induction of Bcl-2 and Bcl-x(L) proteins. Oncogene 21 (1):32–43.
  • Hong, F., S. Radaeva, H. N. Pan, Z. Tian, R. Veech, and B. Gao. 2004. Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease. Hepatology 40 (4):933–941.
  • Horiguchi, N., L. Wang, P. Mukhopadhyay, O. Park, W. I. Jeong, F. Lafdil, D. Osei-Hyiaman, A. Moh, X. Y. Fu, P. Pacher, et al. 2008. Cell type-dependent pro- and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury. Gastroenterology 134 (4):1148–1158.
  • Horton, J. D., J. L. Goldstein, and M. S. Brown. 2002. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. The Journal of Clinical Investigation 109 (9):1125–1131.
  • Hritz, I., P. Mandrekar, A. Velayudham, D. Catalano, A. Dolganiuc, K. Kodys, E. Kurt-Jones, and G. Szabo. 2008. The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88. Hepatology (Baltimore, Md.) 48 (4):1224–1231.
  • Huang, L. L., J. B. Wan, B. Wang, C. W. He, H. Ma, T. W. Li, and J. X. Kang. 2013. Suppression of acute ethanol-induced hepatic steatosis by docosahexaenoic acid is associated with downregulation of stearoyl-CoA desaturase 1 and inflammatory cytokines. Prostaglandins, Leukotrienes and Essential Fatty Acids 88 (5):347–353.
  • Huang, W., B. Wang, X. Li, and J. X. Kang. 2015. Endogenously elevated n-3 polyunsaturated fatty acids alleviate acute ethanol-induced liver steatosis. BioFactors 41 (6):453–462.
  • Ide, T. 2000. Effect of dietary alpha-linolenic acid on the activity and gene expression of hepatic fatty acid oxidation enzymes. BioFactors 13 (1–4):9–14.
  • Ji, C., C. Chan, and N. Kaplowitz. 2006. Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model. Journal of Hepatology 45 (5):717–724.
  • Jimenez-Lopez, J. M., and A. I. Cederbaum. 2005. CYP2E1-dependent oxidative stress and toxicity: Role in ethanol-induced liver injury. Expert Opinion on Drug Metabolism & Toxicology 1 (4):671–685.
  • Johnson, S. B., E. Gordon, C. McClain, G. Low, and R. T. Holman. 1985. Abnormal polyunsaturated fatty acid patterns of serum lipids in alcoholism and cirrhosis: arachidonic acid deficiency in cirrhosis. Proceedings of the National Academy of Sciences of the United States of America 82 (6):1815–1818.
  • Jokelainen, K., L. A. Reinke, and A. A. Nanji. 2001. Nf-kappab activation is associated with free radical generation and endotoxemia and precedes pathological liver injury in experimental alcoholic liver disease. Cytokine 16 (1):36–39.
  • Jump, D. B., K. A. Lytle, C. M. Depner, and S. Tripathy. 2018. Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease. Pharmacology & Therapeutics 181:108–125.
  • Kang, J. X. 2007. Fat-1 transgenic mice: a new model for omega-3 research. Prostaglandins, Leukotrienes and Essential Fatty Acids 77 (5–6):263–267.
  • Kang, J. X., J. Wang, L. Wu, and Z. B. Kang. 2004. Transgenic mice: fat-1 mice convert n-6 to n-3 fatty acids. Nature 427 (6974):504.
  • Kawaratani, H., T. Tsujimoto, A. Douhara, H. Takaya, K. Moriya, T. Namisaki, R. Noguchi, H. Yoshiji, M. Fujimoto, and H. Fukui. 2013. The effect of inflammatory cytokines in alcoholic liver disease. Mediators of Inflammation 2013:495156.
  • Kelly, F. J. 1991. The metabolic role of n-3 polyunsaturated fatty acids: Relationship to human disease. Comparative Biochemistry and Physiology Part A. Comparative Physiology 98 (3–4):581–585.
  • Khoruts, A., L. Stahnke, C. J. McClain, G. Logan, and J. I. Allen. 1991. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 13 (2):267–276.
  • Lakshman, M. R. 2004. Some novel insights into the pathogenesis of alcoholic steatosis. Alcohol (Fayetteville, N.Y.) 34 (1):45–48.
  • Lakshman, M. R., S. J. Chirtel, and L. L. Chambers. 1988. Roles of omega 3 fatty acids and chronic ethanol in the regulation of plasma and liver lipids and plasma apoproteins A1 and E in rats. The Journal of Nutrition 118 (11):1299–1303.
  • Laukoetter, M. G., M. Bruewer, and A. Nusrat. 2006. Regulation of the intestinal epithelial barrier by the apical junctional complex. Current Opinion Gastroenterology 22 (2):85–89.
  • Lian, L. H., Y. L. Wu, S. Z. Song, Y. Wan, W. X. Xie, X. Li, T. Bai, B. Q. Ouyang, and J. X. Nan. 2010. Gentiana manshurica kitagawa reverses acute alcohol-induced liver steatosis through blocking sterol regulatory element-binding protein-1 maturation. Journal of Agricultural and Food Chemistry 58 (24):13013–13019.
  • Lippai, D., S. Bala, D. Catalano, K. Kodys, and G. Szabo. 2014. Micro-RNA-155 deficiency prevents alcohol-induced serum endotoxin increase and small bowel inflammation in mice. Alcoholism: Clinical and Experimental Research 38 (8):2217–2224.
  • Long, Y. C., and J. R. Zierath. 2006. AMP-activated protein kinase signaling in metabolic regulation. The Journal of Clinical Investigation 116 (7):1776–1783.
  • Mandrekar, P., A. Ambade, A. Lim, G. Szabo, and D. Catalano. 2011. An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: Regulation of proinflammatory cytokines and hepatic steatosis in mice. Hepatology 54 (6):2185–2197.
  • Marmillot, P., M. N. Rao, Q. H. Liu, S. J. Chirtel, and M. R. Lakshman. 2000. Effect of dietary omega-3 fatty acids and chronic ethanol consumption on reverse cholesterol transport in rats. Metabolism 49 (4):508–512.
  • Mathurin, P., and R. Bataller. 2015. Trends in the management and burden of alcoholic liver disease. Journal of Hepatology 62 (1 Suppl):S38–S46.
  • Mukherjee, S., S. K. Das, and D. M. Vasudevan. 2007. Effects of ethanol consumption on different Organs-A brief overview. Asian Journal of Biochemistry 2:386–394.
  • Nanji, A. A., A. J. Dannenberg, K. Jokelainen, and N. M. Bass. 2004. Alcoholic liver injury in the rat is associated with reduced expression of peroxisome proliferator-alpha (PPARalpha)-regulated genes and is ameliorated by PPARalpha activation. Journal of Pharmacology and Experimental Therapeutics 310 (1):417–424.
  • Nanji, A. A., K. Jokelainen, G. L. Tipoe, A. Rahemtulla, and A. J. Dannenberg. 2001. Dietary saturated fatty acids reverse inflammatory and fibrotic changes in rat liver despite continued ethanol administration. Journal of Pharmacology and Experimental Therapeutics 299:638–644.
  • Nanji, A. A., S. M. Sadrzadeh, E. K. Yang, F. Fogt, M. Meydani, and A. J. Dannenberg. 1995. Dietary saturated fatty acids: a novel treatment for alcoholic liver disease. Gastroenterology 109 (2):547–554.
  • Nanji, A. A., D. Zakim, A. Rahemtulla, T. Daly, L. Miao, S. Zhao, S. Khwaja, S. R. Tahan, and A. J. Dannenberg. 1997. Dietary saturated fatty acids down-regulate cyclooxygenase-2 and tumor necrosis factor alfa and reverse fibrosis in alcohol-induced liver disease in the rat. Hepatology 26 (6):1538–1545.
  • Nanji, A. A., S. Zhao, S. Sadrzadeh, A. J. Dannenberg, S. R. Tahan, and D. J. Waxman. 1994. Markedly enhanced cytochrome P450 2E1 induction and lipid peroxidation is associated with severe liver injury in fish Oil-Ethanol-Fed rats. Alcoholism: Clinical and Experimental Research 18 (5):1280–1285.
  • Neuman, M. G. 2003. Cytokines-Central factors in alcoholic liver disease. Alcohol Research & Health 27:307–316.
  • Neuman, M. G., Y. Maor, R. M. Nanau, E. Melzer, H. Mell, M. Opris, L. Cohen, and S. Malnick. 2015. Alcoholic liver disease: Role of Cytokines. Biomolecules 5 (3):2023–2034.
  • Nieto, N. 2007. Ethanol and fish oil induce NFkappaB transactivation of the collagen alpha2(I) promoter through lipid peroxidation-driven activation of the PKC-PI3K-Akt pathway. Hepatology (Baltimore, Md.) 45 (6):1433–1445.
  • World Health Organization. 2014. Global status report on alcohol and health 2014. Geneva, Switzerland: WHO Press.
  • Pawlosky, R. J., and N. Salem. Jr.2004. Development of alcoholic fatty liver and fibrosis in rhesus monkeys fed a low n-3 fatty acid diet. Alcoholism, Clinical and Experimental Research 28 (10):1569–1576.
  • Purohit, V., B. Gao, and B. J. Song. 2009. Molecular mechanisms of alcoholic fatty liver. Alcoholism, Clinical and Experimental Research 33 (2):191–205.
  • Purohit, V., D. Russo, and P. M. Coates. 2004. Role of fatty liver, dietary fatty acid supplements, and obesity in the progression of alcoholic liver disease: introduction and summary of the symposium. Alcohol 34 (1):3–8.
  • Rao, R. K., A. Seth, and P. Sheth. 2004. Recent advances in alcoholic liver disease I. Role of intestinal permeability and endotoxemia in alcoholic liver disease. The American Journal of Physiology: Gastrointestinal and Liver Physiology 286 (6):G881–G884.
  • Rogers, C. Q., J. M. Ajmo, and M. You. 2008. Adiponectin and alcoholic fatty liver disease. IUBMB Life 60 (12):790–797.
  • Sachan, D. S., A. M. Yatim, and J. W. Daily. 2002. Comparative effects of dietary corn oil, safflower oil, fish oil and palm oil on metabolism of ethanol and carnitine in the rat. Journal of the American College of Nutrition 21 (3):233–238.
  • Saini, R. K., and Y. S. Keum. 2018. Omega-3 and omega-6 polyunsaturated fatty acids: Dietary sources, metabolism, and significance - A review. Life Sciences 203:255–267.
  • Sekiya, M., N. Yahagi, T. Matsuzaka, Y. Najima, M. Nakakuki, R. Nagai, S. Ishibashi, J. Osuga, N. Yamada, and H. Shimano. 2003. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression. Hepatology 8:1529–1539.
  • Serhan, C. N., J. Dalli, R. A. Colas, J. W. Winkler, and N. Chiang. 2015. Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome. Biochimica et Biophysica Acta 1851 (4):397–413.
  • Simopoulos, A. P. 1991. Omega-3 fatty acids in health and disease and in growth and development. The American Journal of Clinical Nutrition 54 (3):438–463.
  • Simopoulos, A. P. 2008. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Experimental Biology and Medicine (Maywood, N.J.) 233 (6):674–688.
  • Siriwardhana, N., N. S. Kalupahana, and N. Moustaid-Moussa. 2012. Health benefits of n-3 polyunsaturated fatty acids: eicosapentaenoic acid and docosahexaenoic acid. Advances in Food and Nutrition Research 65:211–222.
  • Song, B. J., K. H. Moon, N. U. Olsson, and N. Salem. Jr.2008. Prevention of alcoholic fatty liver and mitochondrial dysfunction in the rat by long-chain polyunsaturated fatty acids. Journal of Hepatology 49 (2):262–273.
  • Song, Z., Z. Zhou, S. Uriarte, L. Wang, Y. J. Kang, T. Chen, S. Barve, and C. J. McClain. 2004. S-adenosylhomocysteine sensitizes to TNF-alpha hepatotoxicity in mice and liver cells: a possible etiological factor in alcoholic liver disease. Hepatology 40 (4):989–997.
  • Sugimoto, K., and Y. Takei. 2017. Pathogenesis of alcoholic liver disease. Hepatology Research: The Official Journal of the Japan Society of Hepatology 47 (1):70–79.
  • Szabo, G. 2015. Gut-liver axis in alcoholic liver disease. Gastroenterology 148 (1):30–36.
  • Szabo, G., and S. Bala. 2010. Alcoholic liver disease and the gut-liver axis. World Journal of Gastroenterology 16 (11):1321–1329.
  • Tamai, H., Y. Horie, S. Kato, H. Yokoyama, and H. Ishii. 2002. Long-term ethanol feeding enhances susceptibility of the liver to orally administered lipopolysaccharides in rats. Alcoholism: Clinical and Experimental Research 26 (1):75S–80S.
  • Tilg, H., R. Jalan, A. Kaser, N. A. Davies, F. A. Offner, S. J. Hodges, O. Ludwiczek, D. Shawcross, H. Zoller, A. Alisa., et al. 2003. Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis. Journal of Hepatology 38 (4):419–425.
  • Tipoe, G. L., E. C. Liong, T. M. Leung, and A. A. Nanji. 2008. A voluntary oral-feeding rat model for pathological alcoholic liver injury. Methods in Molecular Biology 447:11–31.
  • Venkatraman, A., S. Shiva, A. Wigley, E. Ulasova, D. Chhieng, S. M. Bailey, and V. M. Darley-Usmar. 2004. The role of iNOS in alcohol-dependent hepatotoxicity and mitochondrial dysfunction in mice. Hepatology 40 (3):565–573.
  • Viollet, B., B. Guigas, J. Leclerc, S. Hebrard, L. Lantier, R. Mounier, F. Andreelli, and M. Foretz. 2009. AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives. Acta Physiologica 196 (1):81–98.
  • Wada, S., T. Yamazaki, Y. Kawano, S. Miura, and O. Ezaki. 2008. Fish oil fed prior to ethanol administration prevents acute ethanol-induced fatty liver in mice. Journal of Hepatology 49 (3):441–450.
  • Wan, J. B., L. L. Huang, R. Rong, R. Tan, J. Wang, and J. X. Kang. 2010. Endogenously decreasing tissue n-6/n-3 fatty acid ratio reduces atherosclerotic lesions in apolipoprotein E-deficient mice by inhibiting systemic and vascular inflammation. Arteriosclerosis, Thrombosis, and Vascular Biology 30 (12):2487–2494.
  • Wang, M., X. J. Zhang, C. Yan, C. He, P. Li, M. Chen, H. Su, and J. B. Wan. 2016. Preventive effect of α-linolenic acid-rich flaxseed oil against ethanol-induced liver injury is associated with ameliorating gut-derived endotoxin-mediated inflammation in mice. Journal of Functional Foods 23:532–541.
  • Wang, M., X. Zhang, L. J. Ma, R. B. Feng, C. Yan, H. Su, C. He, J. X. Kang, B. Liu, and J. B. Wan. 2017. Omega-3 polyunsaturated fatty acids ameliorate ethanol-induced adipose hyperlipolysis: a mechanism for hepatoprotective effect against alcoholic liver disease. Biochimica et Biophysica Acta 1863 (12):3190–3201.
  • Wang, M., X. J. Zhang, K. Feng, C. He, P. Li, Y. J. Hu, H. Su, and J. B. Wan. 2016. Dietary alpha-linolenic acid-rich flaxseed oil prevents against alcoholic hepatic steatosis via ameliorating lipid homeostasis at adipose tissue-liver axis in mice. Scientific Reports 6:26826.
  • Wang, M., X. J. Zhang, R. Feng, Y. Jiang, D. Y. Zhang, C. He, P. Li, and J. B. Wan. 2017. Hepatoprotective properties of penthorum chinense pursh against carbon tetrachloride-induced acute liver injury in mice. Chinese Medicine 12:32.
  • Wang, M., X. J. Zhang, F. Liu, Y. J. Hu, C. W. He, P. Li, H. X. Su, and J. B. Wan. 2015. Saponins isolated from the leaves of panax notoginseng protect against alcoholic liver injury via inhibiting ethanol-induced oxidative stress and gut-derived endotoxin-mediated inflammation. Journal of Functional Foods 19:214–224.
  • Wang, Y., Y. Liu, A. Sidhu, Z. Ma, C. McClain, and W. Feng. 2012. Lactobacillus rhamnosus GG culture supernatant ameliorates acute alcohol-induced intestinal permeability and liver injury. American Journal of Physiology: Gastrointestinal and Liver Physiology 303 (1):G32–G41.
  • Wang, Y., Y. Zhao, M. Li, Y. Wang, S. Yu, and T. Zeng. 2016. Docosahexaenoic acid supplementation failed to attenuate chronic alcoholic fatty liver in mice. Acta Biochimica et Biophysica Sinica 48 (5):482–484.
  • Wu, D., and A. I. Cederbaum. 2009. Oxidative stress and alcoholic liver disease. Seminars in Liver Disease 29 (2):141–154.
  • Xu, A., Y. Wang, H. Keshaw, L. Y. Xu, K. S. Lam, and G. J. Cooper. 2003. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. Journal of Clinical Investigation 112 (1):91–100.
  • Yates, C. M., P. C. Calder, and G. Ed Rainger. 2014. Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease. Pharmacology & Therapeutics 141:272–282.
  • Yin, Hu-Quan, Young-Tae Je, Young-Chul Kim, Young-Kee Shin, SangHyun Sung, KiYong Lee, Gil-Saeng Jeong, Youn-Chul Kim, and Byung-Hoon Lee. 2009. Magnolia officinalis reverses alcoholic fatty liver by inhibiting the maturation of sterol regulatory element-binding protein-1c. Journal of Pharmacological Sciences 109 (4):486–495.
  • Yin, Hu-Quan, Youn-Chul Kim, Young-Suk Chung, Young-Chul Kim, Young-Kee Shin, and Byung-Hoon Lee. 2009. Honokiol reverses alcoholic fatty liver by inhibiting the maturation of sterol regulatory element binding protein-1c and the expression of its downstream lipogenesis genes. Toxicology and Applied Pharmacology 236 (1):124–130.
  • Yin, M., B. U. Bradford, M. D. Wheeler, T. Uesugi, M. Froh, S. M. Goyert, and R. G. Thurman. 2001. Reduced early alcohol-induced liver injury in CD14-deficient mice. Journal of Immunology (Baltimore, MD: 1950) 166 (7):4737–4742.
  • Yoon, S. J., E. J. Koh, C. S. Kim, O. P. Jee, J. H. Kwak, W. J. Jeong, J. H. Kim, and S. M. Lee. 2012. Agrimonia eupatoria protects against chronic ethanol-induced liver injury in rats. Food and Chemical Toxicology 50 (7):2335–2341.
  • Yoshikawa, T., H. Shimano, N. Yahagi, T. Ide, M. Amemiya-Kudo, T. Matsuzaka, M. Nakakuki, S. Tomita, H. Okazaki, Y. Tamura, et al. 2002. Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements. Journal of Biological Chemistry 277 (3):1705–1711.
  • Zhang, X., S. Tachibana, H. Wang, M. Hisada, G. M. Williams, B. Gao, and Z. Sun. 2010. Interleukin-6 is an important mediator for mitochondrial DNA repair after alcoholic liver injury in mice. Hepatology 52 (6):2137–2147.
  • Zhang, X., H. Wang, P. Yin, H. Fan, L. Sun, and Y. Liu. 2017. Flaxseed oil ameliorates alcoholic liver disease via anti-inflammation and modulating gut microbiota in mice. Lipids in Health and Disease 16:44.
  • Zhong, W., C. J. McClain, M. Cave, Y. J. Kang, and Z. Zhou. 2010. The role of zinc deficiency in alcohol-induced intestinal barrier dysfunction. American Journal of Physiology: Gastrointestinal and Liver Physiology 298 (5):G625–G633.
  • Zhong, W., Y. Zhao, X. Sun, Z. Song, C. J. McClain, and Z. Zhou. 2013. Dietary zinc deficiency exaggerates ethanol-induced liver injury in mice: involvement of intrahepatic and extrahepatic factors. PLoS One 8 (10):e76522.
  • Zhong, Wei, Yantao Zhao, Yunan Tang, Xiaoli Wei, Xue Shi, Wenlong Sun, Xiuhua Sun, Xinmin Yin, Xinguo Sun, Seongho Kim, et al. 2012. Chronic alcohol exposure stimulates adipose tissue lipolysis in mice: role of reverse triglyceride transport in the pathogenesis of alcoholic steatosis. The American Journal of Pathology 180 (3):998–1007.
  • Zhou, Z.,. L. Wang, Z. Song, J. T. Saari, C. J. McClain, and Y. J. Kang. 2005. Zinc supplementation prevents alcoholic liver injury in mice through attenuation of oxidative stress. The American Journal of Pathology 166 (6):1681–1690.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.